Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Biliary Tract Neoplasms × Erlotinib Hydrochloride × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Pancreatic Neoplasms 2 Lung Neoplasms 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Papillary renal cell carcinoma, sporadic 1 Pancreatic Intraductal Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hereditary leiomyomatosis and renal cell cancer 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Adult Solid Neoplasm 1

Interventions

Gemcitabine 13 Cisplatin 12 durvalumab 9 Leucovorin 6 Fluorouracil 5 pembrolizumab 4 Oxaliplatin 4 Nivolumab 4 lenvatinib 3 irinotecan sucrosofate 3 Liquid Biopsy 3 S 1 (combination) 2 Itraconazole 2 Irinotecan 2 Injections 2 Folfox protocol 2 Carboplatin 2 Capecitabine 2 Bevacizumab 2 zanidatamab 1 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 tislelizumab 1 pertuzumab 1 mitazalimab 1 gemcitabine-oxaliplatin regimen 1 devimistat 1 brigimadlin 1 Tegafur 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡